Status:
TERMINATED
Imagery Rescripting for Posttraumatic Nightmares in Rural Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans With Posttraumatic Stress Disorder (PTSD)
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Stress Disorders, Post-Traumatic
Sleep Disorders
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Many service members returning from Iraq and Afghanistan have difficulties adjusting back to civilian life. Research shows that symptoms of posttraumatic stress disorder (PTSD) are particularly high i...
Eligibility Criteria
Inclusion
- Patients for the open trial will be
- OEF/OIF veterans (aged 18-64);
- English-speaking;
- currently enrolled in the Trauma Recovery Program (TRP) at the Michael E. DeBakey Veteran Affairs Medical Center (MEDVAMC);
- reporting at least one combat or war zone associated PTNM in the past week;
- have an existing PTSD International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM); and
- consenting to be in an open trial for treatment of PTNM. In addition, patients must agree to allow their assessment and therapy sessions to be video/audiotaped for the purposes of supervision.
- Pilot Study: Patients for the pilot study will be
- OEF/OIF veterans (aged 18-64);
- English-speaking;
- currently enrolled in the Conroe CBOC for their primary or mental health care;
- reporting at least one combat or war zone associated PTNM in the past week;
- have an existing PTSD ICD-9-CM diagnosis; and
- consenting to be in the pilot study for treatment of PTNM. In addition, patients must agree to allow their assessment and therapy sessions to be video/audiotaped for the purposes of supervision.
Exclusion
- Patients will be excluded for the following reasons:
- current active suicidal/homicidal ideation and intent;
- current substance dependence;
- a diagnosis of bipolar or psychosis;
- active participation in another psychosocial treatment for PTSD;
- prescribed the medication Prazosin (a psychotropic medication for the treatment of nightmares).
- Patients interested in receiving the intervention will not be excluded if they are taking psychotropic medication (except for Prazosin) and may continue to take their medication as prescribed throughout the study.
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00837382
Start Date
January 1 2010
End Date
August 1 2010
Last Update
September 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michael E. DeBakey VA Medical Center (152)
Houston, Texas, United States, 77030